J. Wildhaber (Fribourg, Switzerland), M. Pynenburg (Rotterdam, Netherlands)
Comparison of inflammatory markers and chest CT scan findings in difficult-to-control asthma in children
P. Kenia, M. McFeeters, E. Gaillard, H. Pandya (Leicester, United Kingdom)
|  |
Fatal and near-fatal asthma in children: a two-year nationwide survey in Germany
M. Wisbauer, W. Luise, A. Schuster (Düsseldorf, Germany)
|   |
Non-invasive markers of inflammation as a measurement of corticosteroid responsiveness in children with severe asthma (sa)
C. Bossley, S. Saglani, L. Fleming, N. Wilson, L. Tsartsali, A. Bush (London, United Kingdom)
| |
Ciclosporin as a steroid sparing agent in children with difficult to treat asthma
L. Chapell, C. Tranter, T. Hilliard (Bristol, United Kingdom)
| |
Association of adrenal response in asthmatic children on inhaled steroids with polymorphisms in the genes of glucocorticoid receptor (GR) and corticotropin releasing hormone receptor 1 (CRHR1)
L. Tsartsali, M. Papadopoulos, E. Lagona, A. Papadimitriou, C. Kanaka-Gantenbein, M. Kambouris, G. Chrousos, K. Priftis (Athens, Greece)
| |
Relationship between induced sputum eosinophilia and endothelial dysfunction in children with bronchial asthma
Y. Antipkin, V. Lapshyn, T. Umanets, A. Nakonechna (Kyiv, Ukraine; Liverpool, United Kingdom)
| |
Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline
J. Bousquet, M. Kulus, H. Fox, M. Blogg, A. Fowler-Taylor, C. Fernandez-Vidaurre (Montpellier, France; Warsaw, Poland; West Sussex, United Kingdom; East Hanover, United States Of America)
| |
Value of home spirometry to diagnose asthma in children with chronic respiratory symptoms of unknown origin
A. Brouwer, C. Visser, E. Duiverman, P. Brand (Groningen, Zwolle, Netherlands)
| |